Impact of treatment sequence on the outcomes of metastatic castration resistant prostate cancer patients (mCRPC) with germline BRCA2 mutations: A subanalysis of the PROREPAIR-B study

Autor:	Elena Castro, Jose Maria M. Piulats Rodriguez, Enrique Gonzalez-Billalabeitia, David Lorente, Pablo Borrega, Rebeca Lozano, Alejo Rodriguez Vida, Aranzazu Gonzalez del Alba, Rafael Morales Barrera, Angela del Pozo, Iciar Garcia Carbonero, Pablo Lapunzina, Javier Puente, M Isabel Sáez, Eva Fernandez Parra, Nuria Romero-Laorden, María José Méndez-Vidal, Ana Medina, David Olmos, Colin C. Pritchard
Rok vydání:	2018
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Treatment sequence Castration resistant medicine.disease Germline Prostate cancer Germline mutation Internal medicine medicine Prospective cohort study business
Zdroj:	Journal of Clinical Oncology. 36:5071-5071
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2018.36.15_suppl.5071
Popis:	5071Background: Germline mutations in BRCA2 have been identified in 3-5% of mCRPC patients. PROREPAIR-B (Castro et al ESMO 2017) is the first prospective study to report a worse survival from mCRPC...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3b48d06df186b2d54c36dcc120b14a15 https://doi.org/10.1200/jco.2018.36.15_suppl.5071 Zobrazit plný text záznamu